Empagliflozin Treatment is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes

Thirunavukarasu, S, Jex, N, Chowdhary, A et al. (13 more authors) (2021) Empagliflozin Treatment is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes. Diabetes. ISSN 0012-1797

Abstract

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics